Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems

Youngha Kim ^# 1, Danbee Kang ^# 1 2, Eunjee Kang ^1 3, Jihyun Lim ¹, Sooyeon Kim ^1 2, Heesu Nam ^1 2, Sungkeun Shim ^1 4, Mangyeong Lee ^1 4, Young-Wan Moon ⁵, Seung-Jae Lim ⁵, Ki-Sun Sung ⁶, Juhee Cho ^{7 8 9 10 11}

Affiliations expand

• PMID: 34819153
• PMCID: PMC8614031
• DOI: 10.1186/s13102-021-00374-1

Free PMC article

Full text linksCite

Abstract

Background: Patients with lower extremity problems (LEP) commonly experience functional loss, pain, decreased range of motion, inadequacy in daily living activities, and structural change in radiographic evaluations. However, the traditional patient-reported outcome measurement which focused on symptoms, had a limited scope of applicability. This study aimed to validate the psychometric properties of the Korean version of PROMIS-29 Profile v2.1 (K-PROMIS-29 V2.1), a multi-dimensional measure for assessing generic profile health-related quality-of-life (HRQoL) in a sample of patients with lower extremity problems (LEP).

Methods: Participants were recruited from the orthopedic outpatient clinics at the Samsung Medical Center in Seoul, South Korea from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the SF-36v2. Principal component analysis (PCA) and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1.

Results: A total of 299 participants were enrolled in the study and 258 (86%) completed the study questionnaire. The mean age (SD) of the participants was 56.6 (14.5) and 32.3%, 29.8, and 25.2% of the study participants visited outpatient clinics for foot, knee, and hip problems respectively. The Cronbach's alpha coefficients of 7 sub-domains in K-PROMIS-29 V2.1 ranged from 0.80 to 0.95, indicating satisfactory internal consistency. In CFA, the goodness-of-fit indices were high (CFI = 0.937 and SRMR = 0.061). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the SF-36v2 (r = 0.55-0.70).

Conclusions: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing a broad range of health-related quality-of-life domains in patients with LEP. It would reflect the real-life symptoms experienced by patients with LEP.

Keywords: Function; Lower extremity problems; PROMIS-29; Quality of life; validation.